Key result
Statin therapy does not alter fasting versus non-fasting lipid variations in normal-triglyceride patients.
Why the study?
The impact of statin use on non-fasting plasma lipid measurements has not been thoroughly evaluated.
Does statin treatment affect the difference between fasting and non-fasting lipid measurements in patients with normal triglyceride levels?
Cross-Sectional (n=686)
Does statin treatment affect the difference between fasting and non-fasting lipid measurements in patients with normal triglyceride levels?
Non-fasting lipid measurements are acceptable for patients receiving statin treatment, as statin use does not significantly alter the difference between fasting and non-fasting lipid profiles.
Non-fasting lipids appear reliable in statin users; leaves open need for prospective trials before guideline change.
BACKGROUND: Non-fasting blood samples are routinely used to assess plasma lipid profiles except in patients with severe hypertriglyceridemia according to the previous consensus. However, the impact of statin use on non-fasting plasma lipid measurements has not been thoroughly evaluated. METHODS: In this cross-sectional study, 686 patients with normal triglyceride (TG) levels, who were hospitalized due to chest pain, were enrolled. Fasting (8-12 h) and non-fasting (2-4 h after breakfast) lipid profiles were measured on the second day of admission. Patients were divided into the non-statin (n=499) group and statin treatment (n=187) group. Differences in fasting and non-fasting lipid profiles between the statin and non-statin groups were compared. RESULTS: The mean age of participants was 57±13 years, and 54.4% were male. A linear correlation was observed between fasting and non-fasting lipid profiles. Although a postprandial impact on lipid parameters was observed, the general pattern of differences between fasting and non-fasting lipids was similar in both groups. Additionally, the diff(%) [(non-fasting-fasting)/fasting ×100%] of lipid panels did not vary by statin treatment. Moreover, no effects of statin types or duration of use on non-fasting lipid profiles were identified. CONCLUSIONS: The current study found fasting and non-fasting lipid panels were similar in individuals with or without statin treatment. Non-fasting lipid panels were not significantly affected by statin types or duration of use, suggesting that non-fasting lipid measurement is an acceptable test for patients receiving statin treatment.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) conducted a cross-sectional in Chest pain with normal triglyceride levels (n=686). Statin treatment vs. Non-statin treatment was evaluated on Difference between fasting and non-fasting lipid profiles (diff(%)). Statin treatment did not significantly affect the percentage difference between fasting and non-fasting lipid profiles in patients with normal triglyceride levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: